跳至主要内容
临床试验/NCT02688699
NCT02688699尚未招募4 期

Italian Multicenter Prospective Randomized Trial to Compare Additive Hemostatic Efficacy of EndoClot System to Prevent Bleeding After Endoscopic Mucosal Resection or Endoscopic Submucosal Dissection of Lesions in the Gastrointestinal Tract

University of Turin, Italy0 个研究点目标入组 288 人开始时间: 2023年9月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
288
主要终点
effectiveness of EndoClotTM in preventing post-procedural bleeding

研究概览

简要总结

The investigators want to verify in a randomised trial, the effectiveness of EndoClotTM in preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD (Endoscopic Submucosal Dissection) for sessile lesions >20 mm in the right colon

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •>18 years old
  • •lesions suitable for EMR or ESD
  • •site in the right colon

排除标准

  • •Severe cardiovascular pathologies
  • •Liver and Urinary dysfunctions
  • •Hematologic diseases
  • •Pregnancy and breast feeding
  • •impossible follow-up
  • •platelet and coagulation disorders (PLT < 50 x 109/L, INR > 2)
  • •Sensitivity or allergy to the drug

研究组 & 干预措施

control

No Intervention

EndoClot

Experimental

spraying of Endoclot powder after EMR or ESD

干预措施: EndoClot (Procedure)

结局指标

主要结局

effectiveness of EndoClotTM in preventing post-procedural bleeding

时间窗: 14 days

The investigators want to verify in a randomised trial, the effectiveness of EndoClotTM in preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD (Endoscopic Submucosal Dissection) for sessile lesions \>20 mm in the right colon

次要结局

未报告次要终点

研究者

发起方
University of Turin, Italy
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alberto Arezzo

Associate Professor of Surgery, MD

University of Turin, Italy

相似试验